Colon cancer stem cells

Lucia Ricci-Vitiani, Eros Fabrizi, Elisabetta Palio, Ruggero De Maria

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

Colorectal cancer (CRC) is the third most common form of cancer and the second cause of cancer-related death in the Western world, leading to 655,000 deaths worldwide per year (Jemal et al. in CA Cancer J Clin 56:106-130, 2006). Despite the emergence of new targeted agents and the use of various therapeutic combinations, none of the treatment options available is curative in patients with advanced cancer. A growing body of evidence is increasingly supporting the idea that human cancers can be considered as a stem cell disease. According to the cancer stem cell model, malignancies originate from a small fraction of cancer cells that show self-renewal and pluripotency and are capable of initiating and sustaining tumor growth (Boman and Wicha in J Clin Oncol 26:2795-2799, 2008). The cancer-initiating cells or "cancer stem cells" were first identified in hematologic malignancies and most recently in several solid tumors, including CRC. The hypothesis of stem cell-driven tumorigenesis in colon cancer raises questions as to whether current treatments are able to efficiently target the tumorigenic cell population that is responsible for tumor growth and maintenance. This review will focus on the different aspects of stem cell biology in the context of CRC, which might help to understand the mechanisms that give rise to tumor development and resistance to therapy. First, we will briefly revise the knowledge available on normal intestinal stem cells and recent advances in understanding crypt biology, which have led to new theory on the origins of colon adenomas and cancers. Then, we will summarize the evidence and current status on colon cancer stem cells, focusing on their relevance and promises for the treatment of colorectal carcinoma.

Original languageEnglish
Pages (from-to)1097-1104
Number of pages8
JournalJournal of Molecular Medicine
Volume87
Issue number11
DOIs
Publication statusPublished - Nov 2009

Fingerprint

Neoplastic Stem Cells
Colonic Neoplasms
Neoplasms
Colorectal Neoplasms
Stem Cells
Western World
Second Primary Neoplasms
Therapeutic Uses
Hematologic Neoplasms
Therapeutics
Growth
Adenoma
Cell Biology
Carcinogenesis
Maintenance

Keywords

  • Colon cancer-initiating cells
  • Colon carcinogenesis
  • Intestinal stem cells

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics(clinical)
  • Drug Discovery

Cite this

Ricci-Vitiani, L., Fabrizi, E., Palio, E., & De Maria, R. (2009). Colon cancer stem cells. Journal of Molecular Medicine, 87(11), 1097-1104. https://doi.org/10.1007/s00109-009-0518-4

Colon cancer stem cells. / Ricci-Vitiani, Lucia; Fabrizi, Eros; Palio, Elisabetta; De Maria, Ruggero.

In: Journal of Molecular Medicine, Vol. 87, No. 11, 11.2009, p. 1097-1104.

Research output: Contribution to journalArticle

Ricci-Vitiani, L, Fabrizi, E, Palio, E & De Maria, R 2009, 'Colon cancer stem cells', Journal of Molecular Medicine, vol. 87, no. 11, pp. 1097-1104. https://doi.org/10.1007/s00109-009-0518-4
Ricci-Vitiani, Lucia ; Fabrizi, Eros ; Palio, Elisabetta ; De Maria, Ruggero. / Colon cancer stem cells. In: Journal of Molecular Medicine. 2009 ; Vol. 87, No. 11. pp. 1097-1104.
@article{cad03b7e78e54f9a8bc903ebb9818cb6,
title = "Colon cancer stem cells",
abstract = "Colorectal cancer (CRC) is the third most common form of cancer and the second cause of cancer-related death in the Western world, leading to 655,000 deaths worldwide per year (Jemal et al. in CA Cancer J Clin 56:106-130, 2006). Despite the emergence of new targeted agents and the use of various therapeutic combinations, none of the treatment options available is curative in patients with advanced cancer. A growing body of evidence is increasingly supporting the idea that human cancers can be considered as a stem cell disease. According to the cancer stem cell model, malignancies originate from a small fraction of cancer cells that show self-renewal and pluripotency and are capable of initiating and sustaining tumor growth (Boman and Wicha in J Clin Oncol 26:2795-2799, 2008). The cancer-initiating cells or {"}cancer stem cells{"} were first identified in hematologic malignancies and most recently in several solid tumors, including CRC. The hypothesis of stem cell-driven tumorigenesis in colon cancer raises questions as to whether current treatments are able to efficiently target the tumorigenic cell population that is responsible for tumor growth and maintenance. This review will focus on the different aspects of stem cell biology in the context of CRC, which might help to understand the mechanisms that give rise to tumor development and resistance to therapy. First, we will briefly revise the knowledge available on normal intestinal stem cells and recent advances in understanding crypt biology, which have led to new theory on the origins of colon adenomas and cancers. Then, we will summarize the evidence and current status on colon cancer stem cells, focusing on their relevance and promises for the treatment of colorectal carcinoma.",
keywords = "Colon cancer-initiating cells, Colon carcinogenesis, Intestinal stem cells",
author = "Lucia Ricci-Vitiani and Eros Fabrizi and Elisabetta Palio and {De Maria}, Ruggero",
year = "2009",
month = "11",
doi = "10.1007/s00109-009-0518-4",
language = "English",
volume = "87",
pages = "1097--1104",
journal = "Journal of Molecular Medicine",
issn = "0946-2716",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - Colon cancer stem cells

AU - Ricci-Vitiani, Lucia

AU - Fabrizi, Eros

AU - Palio, Elisabetta

AU - De Maria, Ruggero

PY - 2009/11

Y1 - 2009/11

N2 - Colorectal cancer (CRC) is the third most common form of cancer and the second cause of cancer-related death in the Western world, leading to 655,000 deaths worldwide per year (Jemal et al. in CA Cancer J Clin 56:106-130, 2006). Despite the emergence of new targeted agents and the use of various therapeutic combinations, none of the treatment options available is curative in patients with advanced cancer. A growing body of evidence is increasingly supporting the idea that human cancers can be considered as a stem cell disease. According to the cancer stem cell model, malignancies originate from a small fraction of cancer cells that show self-renewal and pluripotency and are capable of initiating and sustaining tumor growth (Boman and Wicha in J Clin Oncol 26:2795-2799, 2008). The cancer-initiating cells or "cancer stem cells" were first identified in hematologic malignancies and most recently in several solid tumors, including CRC. The hypothesis of stem cell-driven tumorigenesis in colon cancer raises questions as to whether current treatments are able to efficiently target the tumorigenic cell population that is responsible for tumor growth and maintenance. This review will focus on the different aspects of stem cell biology in the context of CRC, which might help to understand the mechanisms that give rise to tumor development and resistance to therapy. First, we will briefly revise the knowledge available on normal intestinal stem cells and recent advances in understanding crypt biology, which have led to new theory on the origins of colon adenomas and cancers. Then, we will summarize the evidence and current status on colon cancer stem cells, focusing on their relevance and promises for the treatment of colorectal carcinoma.

AB - Colorectal cancer (CRC) is the third most common form of cancer and the second cause of cancer-related death in the Western world, leading to 655,000 deaths worldwide per year (Jemal et al. in CA Cancer J Clin 56:106-130, 2006). Despite the emergence of new targeted agents and the use of various therapeutic combinations, none of the treatment options available is curative in patients with advanced cancer. A growing body of evidence is increasingly supporting the idea that human cancers can be considered as a stem cell disease. According to the cancer stem cell model, malignancies originate from a small fraction of cancer cells that show self-renewal and pluripotency and are capable of initiating and sustaining tumor growth (Boman and Wicha in J Clin Oncol 26:2795-2799, 2008). The cancer-initiating cells or "cancer stem cells" were first identified in hematologic malignancies and most recently in several solid tumors, including CRC. The hypothesis of stem cell-driven tumorigenesis in colon cancer raises questions as to whether current treatments are able to efficiently target the tumorigenic cell population that is responsible for tumor growth and maintenance. This review will focus on the different aspects of stem cell biology in the context of CRC, which might help to understand the mechanisms that give rise to tumor development and resistance to therapy. First, we will briefly revise the knowledge available on normal intestinal stem cells and recent advances in understanding crypt biology, which have led to new theory on the origins of colon adenomas and cancers. Then, we will summarize the evidence and current status on colon cancer stem cells, focusing on their relevance and promises for the treatment of colorectal carcinoma.

KW - Colon cancer-initiating cells

KW - Colon carcinogenesis

KW - Intestinal stem cells

UR - http://www.scopus.com/inward/record.url?scp=70449524235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449524235&partnerID=8YFLogxK

U2 - 10.1007/s00109-009-0518-4

DO - 10.1007/s00109-009-0518-4

M3 - Article

C2 - 19727638

AN - SCOPUS:70449524235

VL - 87

SP - 1097

EP - 1104

JO - Journal of Molecular Medicine

JF - Journal of Molecular Medicine

SN - 0946-2716

IS - 11

ER -